GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Kedudukan dalam Saham
#3668
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Harga Saham
$27.17
Modal Pasaran
$4.60B
Perubahan (1 hari)
-1.33%
Perubahan (1 tahun)
-13.30%
Negara
IN
Perdagangan GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Sejarah pecahan saham untuk GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Saham GlaxoSmithKline Pharmaceuticals Limited (simbol: GLAXO) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Sep 11, 2018.
Satu saham GLAXO yang dibeli sebelum Sep 11, 2018 kini bersamaan dengan 2 saham GLAXO.
Pecahan saham terkini berlaku pada Sep 11, 2018.
Satu saham GLAXO yang dibeli sebelum Sep 11, 2018 kini bersamaan dengan 2 saham GLAXO.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2018-09-11 | 2:1 | x2 | x2 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
